FKBP5 and Stroke: Targeting FKBP51, whether through pharmacological inhibition or neuromodulation, may offer a promising translational approach to overcoming the limitations of current stroke therapies by shifting focus from direct receptor blockade to the modulation of intracellular signaling pathways.